Urology Book

http://www.fpnotebook.com/

ViagraAka: Sildenafil

Advertisement

  1. Indications
    1. Psychogenic Impotence
    2. Neurogenic Impotence
    3. Vasculogenic Impotence
  2. Contraindications
    1. Absolute Contraindications
      1. Men using nitrates (causes profound hypotension)
    2. Relative Contraindications
      1. Active coronary ischemia in men not on nitrates
      2. Congestive Heart Failure
        1. Borderline low Blood Pressure
        2. Bordrline low volume status
      3. Multidrug antihypertensive regimen
      4. Taking Cytochrome P450-3A4 (CYP3A4) inhibitor
    3. Areas where sildenafil may be used safely
      1. Safe in stable coronary disease (no nitrates)
        1. Debusk (2004) Am J Cardiol 93:147
  3. Mechanism
    1. Phosphodiesterase Type 5 causes Erection to subside
    2. Viagra blocks Phosphodiesterase Type 5
      1. Results in enhanced Erection if man is aroused
      2. Unlike Alprostadil, will not cause Erection
    3. Viagra enhances vasodilating effect of Nitrous Oxide
      1. Normally released during sexual stimulation
  4. Pharmacokinetics
    1. Peak: 1 hour if taken while fasting
      1. Peak delayed by 1 hour if taken with fatty meal
    2. Half Life: 4 hours
    3. Metabolized by Liver and excreted mostly in stool
      1. Clearance delayed in age over 65 years
      2. Clearance delayed in Liver disease
  5. Dosing
    1. Start 50 mg PO 1 hour before intercourse
      1. Do not take more than once per day
      2. Most insurance limits to 6 per month
    2. Indications to start with half dosing (25 mg)
      1. Age over 65 years
      2. Hepatic Impairment
      3. Renal Impairment
    3. Consider crushing tablet and placing under Tongue
      1. May increase onset of action to 15 minutes
      2. May also increase absorption
        1. Consider lowering dose
  6. Efficacy
    1. Benefits those with organic and psychological Impotence
    2. Initial studies showed improved Erections in 70%
    3. Over Placebo, 3.6 times more likely to improve Erection
      1. Burls (2001) Br J Gen Pract 51:1004
  7. Drug Interactions
    1. Inhibit breakdown of Viagra via Cytochrome P3A4
      1. Cimetidine (Tagamet)
      2. Erythromycin
      3. Ketoconazole (Nizoral)
      4. Itraconazole (Sporonox)
      5. Mibefradil (Posicor)
    2. Profound Vasodilitation and Hypotension (Avoid)
      1. Nitrates
  8. Adverse Effects
    1. Hypotensive effect for men on Nitrates (Avoid)
    2. Vision effects
      1. Temporary color vision disturbance (6%)
        1. Blue colors may appear to be green
      2. Blurred vision or Vision Loss
        1. Higher risk if atherosclerosis
        2. Rare occurence, but can be permanent
        3. Appears to occur with Levitra and Cialis as well
    3. Mild Headache (21%)
    4. Facial Flushing (27%)
    5. Indigestion or Dyspepsia (11%)
    6. Does not cause Priapism
  9. Cost
    1. Wholesale: $7 per pill
  10. Reference
    1. Boolell (1996) Br J Urol 78:257
    2. Cheitlin (1999) J Am Coll Cardiol 33:273
    3. (1998) Med Lett Drugs Ther 40(1026):51
    4. Rendell (1999) JAMA 281(5):421

sildenafil (C0529793)

Definition (PDQ)The citrate salt of a pyrazolopyrimidinone derivative structurally related to zaprinast. Sildenafil selectively inhibits cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase, resulting in vasodilation in the corpus cavernosum of the penis and penile erection. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=269137&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=269137&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26670" NCI Thesaurus)
ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
MSHC101426
Englishsildenafil, SILDENAFIL PREPARATION
Spanishsildenafil, sildenafilo
Parent ConceptsPhosphodiesterase Inhibitors (C0031638), Piperazines (C0031958), [GU900] GENITOURINARY AGENTS, OTHER (C0973562), Antispasmodics (C0037766), Smooth muscle relaxant (C0304437), Phosphodiesterase 5 inhibitor (C1318700), Genital system agent (C1320003), Drug allergen (C1320237)
SourcesMSH, NCI, NDFRT, PDQ, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF
Derived from the NIH UMLS (Unified Medical Language System)


Viagra (C0663448)

ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
MSHC101426
EnglishAbbott brand of sildenafil citrate, Pfizer brand 1 of sildenafil citrate, Viagra
SourcesMSH, NCI, PDQ, RXNORM
Derived from the NIH UMLS (Unified Medical Language System)



Navigation Tree